monoethylglycinexylidide has been researched along with Hepatic Encephalopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botta, F; Fasoli, A; Giannini, E; Risso, D; Romagnoli, P; Testa, R | 1 |
| Becker, H; Ebener, T; Groteguth, R; Niederau, C; Stremmel, W; Strohmeyer, G; Wojdat, R; Zoedler, M | 1 |
2 other study(ies) available for monoethylglycinexylidide and Hepatic Encephalopathy
| Article | Year |
|---|---|
The monoethylglycinexylidide test does not impair psychometric performance in patients with chronic hepatitis or cirrhosis.
Topics: Adult; Aged; Female; Hepatic Encephalopathy; Hepatitis, Chronic; Humans; Lidocaine; Liver Cirrhosis; Male; Middle Aged | 2000 |
[Liver function tests in a clinical comparison].
Topics: Cholinesterases; Factor V; Factor VII; Galactose; Hepatic Encephalopathy; Humans; Indocyanine Green; Lidocaine; Liver Cirrhosis; Liver Function Tests; Metabolic Clearance Rate; Prealbumin; Prothrombin Time; Reference Values; Serum Albumin | 1992 |